Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1631-2023Class II

ADVIA Chemistry ToxAmmonia Calibrator- In vitro diagnostic use in the calibration of ethanol (ETOH_2)...

Siemens Healthcare Diagnostics Inc. / initiated 2023-04-05 / Open, Classified / root cause: manufacturing process

Siemens Healthcare Diagnostics, Inc. began a recall of ADVIA Chemistry ToxAmmonia Calibrator- In vitro diagnostic use in the calibration of ethanol (ETOH_2), ammonia (AMM), acetaminophen (ACET), and salicylate... on . FDA classified it as Class II and gives the reason as "Reassignment of the Atellica CH Toxicology Calibrators (TOX CAL) and ADVIA Chemistry ToxAmmonia Calibrators for the Atellica CH Salicylate (Sal) Assay due to a positive bias". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1631-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
ADVIA Chemistry ToxAmmonia Calibrator- In vitro diagnostic use in the calibration of ethanol (ETOH_2), ammonia (AMM), acetaminophen (ACET), and salicylate (SAL) assays on the ADVIA Chemistry systems Siemens Material Number (SMN): 10309217
Product code
JLX Radioimmunoassay, 17-Hydroxyprogesterone
Reason for recall
Reassignment of the Atellica CH Toxicology Calibrators (TOX CAL) and ADVIA Chemistry ToxAmmonia Calibrators for the Atellica CH Salicylate (Sal) Assay due to a positive bias
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
Siemens issued Urgent Medical Device Corrections (UMDC) ACHC23-03.A.US and ACHC23- 03.A.US.CHC to US customers via FedEx beginning on 04/05/2023. An Urgent Field Safety Notices (UFSN) ACHC23-03.A.OUS and ACHC23-03.A.OUS.CHC issued to OUS Siemens reporting sites with affected customers, for distribution and regional reporting to their local competent authorities beginning on 04/05/2023. Letter states reason for recall, health risk and action to take: Please review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable. Until the updated lot-specific value sheets are available on Document Library, keep a copy of this letter as a reference for the updated salicylate calibrator values. Perform the instructions provided in Additional Information section below. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. If you have received any complaints of illness or adverse events associated with the products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Quantity in commerce
447 unit US; 1537 units OUS
Distribution
US Nationwide and Worldwide Distribution Foreign: Argentina Australia Austria¿¿¿¿¿¿¿¿ Bahrain¿¿¿¿¿¿¿¿ Bangladesh Belgium¿¿¿¿¿¿¿¿ Bosnia¿Herzeg.¿ Brazil Canada Chile China Colombia Czech¿Republic¿ Egypt¿¿¿¿¿¿¿¿¿¿ Estonia¿¿¿¿¿¿¿¿ Finland¿¿¿¿¿¿¿¿ France¿¿¿¿¿¿¿¿¿ Georgia¿¿¿¿¿¿¿¿ Germany¿¿¿¿¿¿¿¿ Greece¿¿¿¿¿¿¿¿¿ Hong Kong Hungary¿¿¿¿¿¿¿¿ India Israel¿¿¿¿¿¿¿¿¿ Italy¿¿¿¿¿¿¿¿¿¿ Latvia¿¿¿¿¿¿¿¿¿ Malaysia Mexico Netherlands¿¿¿¿ Norway¿¿¿¿¿¿¿¿¿ Pakistan¿¿¿¿¿¿¿ Poland¿¿¿¿¿¿¿¿¿ Portugal¿¿¿¿¿¿¿ Republic of Korea Saudi¿Arabia¿¿¿ Serbia¿¿¿¿¿¿¿¿¿ Slovakia¿¿¿¿¿¿¿ South Africa Spain¿¿¿¿¿¿¿¿¿¿ Sweden¿¿¿¿¿¿¿¿¿ Taiwan Turkey¿¿¿¿¿¿¿¿¿ United¿Kingdom¿ Uruguay Vietnam
Product codes and lots
UDI-DI: 00630414479286 Lot Numbers: 9520531 Exp.Date: 2023-05-31; 9520341 Exp. Date: 2024-03-31

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1631-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1631-2023Class IIOngoingVoluntary: Firm initiated
Z-1632-2023Class IIOngoingVoluntary: Firm initiated